Nearly half of the organizations in the CMS' largest test of accountable care slowed Medicare spending, but just 29 of 114 ACOs saved enough to receive bonus payments, the agency said.
Nearly half of the organizations in the CMS' largest test of accountable care slowed Medicare spending, but just 29 of 114 ACOs saved enough to receive bonus payments, the agency said.
Medicare launched its shared-savings program, one of two Medicare accountable care initiatives, in April 2012 with 27 organizations that agreed to try to save money and improve quality in exchange for the chance to keep some of the savings they produced. Three months later, the program added another 87 organizations.
Medicare spending was lower than projected among 54 of the ACOs during the first 12 months of the effort, the agency's interim data show. Twenty-nine ACOs reduced Medicare spending enough to keep a share of the savings. The ACOs produced shared savings of $126 million, and Medicare will see $128 million in savings, the CMS announced.
Read the full story here: http://bit.ly/1iPGAcq
Source: Modern Healthcare
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Real-World Data Show Poor Outcomes Among Patients With ACS and Blood Cancers
December 8th 2023A real-world analysis found that patients with acute coronary syndrome who were also diagnosed with a hematologic malignancy had worse survival outcomes, and patients with multiple myeloma were overrepresented in the population.
Read More